Pharmacotherapy
-
Multicenter Study Comparative Study Clinical Trial
Erythropoietic response to two epoetin alfa regimens in critically ill patients: a pilot study.
To compare the erythropoietic responses and tolerability of two recombinant human erythropoietin (EPO) regimens. ⋯ Although the study had limitations, it suggested that EPO 40,000 U twice/week did not increase or sustain stimulation of the erythropoietic response compared with EPO 40,000 U/week in critically ill patients.